Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreSpecies
Cynomolgus macaques are a widely used NHP model for pharmacokinetic and pharmacodynamic profiling, safety and toxicology assessment, and immunology research. Alpha Genesis supports GLP and non-GLP studies and qualified animal supply under AAALAC-accredited, USDA-licensed facility standards, serving North American and global development programs.
Macaca fascicularis is the most widely used NHP in regulated preclinical safety evaluation, with extensive regulatory precedent across ICH and FDA guidance documents. The species is particularly well suited to toxicokinetics, repeat-dose toxicology, immunogenicity assessment, safety pharmacology, and PK/PD studies supporting biologic and small-molecule drug development programs, including global development programs and studies designed to support international regulatory submissions, where appropriate.
Alpha Genesis supports cynomolgus programs with deep experience in regulated NHP safety evaluation and the veterinary depth to match. Purpose-bred animals are cared for by primate specialists who deliver species-specific enrichment, social housing, and behavioral management alongside structured health monitoring, care that protects both animal wellbeing and the integrity of regulated data, because excellent welfare is fundamental to excellent science. Operations are AAALAC accredited, USDA registered, OLAW assured, and supported by IACUC oversight and experienced veterinary care, with study documentation consistent with internationally recognized GLP expectations. All study and supply engagements are subject to protocol review and scope qualification.
Cynomolgus macaques are readily available to research clients, with worldwide shipping and cross-border supply support available for multinational sponsors. Scope is confirmed during protocol review. Animal supply and logistics are conducted with full veterinary, regulatory, transportation, import/export, permitting, and animal-welfare documentation.
Cynomolgus macaques are used across pharmaceutical development, academic investigation, and government-funded programs. We support the following segments, subject to scope qualification.
Sponsors requiring IND-enabling and regulatory-track NHP toxicology, safety pharmacology, PK/PD, and immunogenicity evaluation in a species with broad regulatory precedent, supporting North American and global development programs.
Investigator-led research programs in immunology, virology, and translational pharmacology requiring characterized cynomolgus models, biospecimen access, and flexible study support.
Programs supporting countermeasure development, biodefense, or long-term colony programs requiring documented health status and compliance-ready operations.
Contract research organizations and sponsor-CRO partnerships seeking NHP capacity, species-specific expertise, or biospecimen services to extend program capabilities.
Cynomolgus macaques support a broad range of preclinical research applications with well-established regulatory and scientific precedent.
Program engagement can be structured around study execution, animal supply, or combined services. Scope and feasibility are confirmed during protocol review.
End-to-end in-life study support including animal assignment, dosing, in-life monitoring, sample collection, necropsy, and data reporting. GLP and non-GLP options available for qualified protocols.
Supply of health-screened cynomolgus macaques meeting sponsor specifications. All supply subject to applicable veterinary, regulatory, transportation, and permitting requirements.
Serial and terminal biospecimen collection, processing, cryopreservation, and logistics from colony or study animals. Chain-of-custody documentation provided.
Compliance is expected; how animals are cared for is what differentiates a program. In regulated toxicology, that veterinary and welfare depth directly protects data integrity for cynomolgus studies, with accreditation and oversight providing the backing.
Cynomolgus macaques carry extensive regulatory precedent in ICH and FDA-guided toxicology and safety evaluation. Our team has experience aligning study designs with current U.S. and international regulatory expectations, supporting sponsors running global development programs.
GLP and non-GLP study support is available for research clients, enabling programs to scale from early-stage investigation to regulatory-submission-supporting studies within a single facility, with documentation consistent with internationally recognized GLP expectations.
Qualified animal supply and study execution within the same organization reduces handoffs, supports data traceability, and allows for coordinated acclimation and protocol timelines.
Resident veterinary professionals provide clinical oversight, protocol consultation, procedure execution, and continuous welfare monitoring throughout the life of each program.
SOP-governed operations, structured records, and sponsor audit programs support regulatory review and inspection readiness for IND-enabling and post-IND programs.
Program managers and study directors engage early to review study design, identify logistical considerations, and provide operational continuity from initiation to final sample delivery.
Alpha Genesis maintains established cynomolgus macaque colonies with consistent availability for research clients, supporting both one-time and ongoing program requirements. Contact us to confirm cohort specifications and timeline.
Submit a protocol for review or request a consultation to discuss study design, animal availability, and program fit with our scientific and operations team.
